Personal tools

MCL coexpression mm9:219

From FANTOM5_SSTAR

Revision as of 16:10, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0006953;acute-phase response;0.0275006151367407;19695!GO:0035300;inositol trisphosphate 5/6-kinase activity;0.027803648715...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr11:68369811..68369821,+p5@Mfsd6l
Mm9::chr11:78734321..78734336,+p1@Nos2
Mm9::chr12:103965542..103965564,-p@chr12:103965542..103965564
-
Mm9::chr12:77896303..77896342,-p@chr12:77896303..77896342
-
Mm9::chr15:94459667..94459701,+p1@Tmem117
Mm9::chr16:18629886..18629899,-p@chr16:18629886..18629899
-
Mm9::chr16:33794199..33794208,+p7@Muc13
Mm9::chr16:33794221..33794247,+p5@Muc13
Mm9::chr16:34943355..34943373,-p@chr16:34943355..34943373
-
Mm9::chr17:24835239..24835290,+p1@Noxo1
Mm9::chr17:37004048..37004055,-p4@Trim15
Mm9::chr17:37004061..37004104,-p1@Trim15
Mm9::chr18:35886629..35886648,+p1@1700066B19Rik
Mm9::chr18:35886673..35886693,+p3@1700066B19Rik
Mm9::chr19:41337833..41337868,+p@chr19:41337833..41337868
+
Mm9::chr3:103636664..103636763,+p1@Bcl2l15
Mm9::chr4:133899408..133899421,+p9@Slc30a2
Mm9::chr6:78321036..78321044,+p@chr6:78321036..78321044
+
Mm9::chr6:78323455..78323458,-p@chr6:78323455..78323458
-
Mm9::chr6:78416391..78416410,+p@chr6:78416391..78416410
+
Mm9::chr6:78416506..78416522,-p@chr6:78416506..78416522
-
Mm9::chr6:78416766..78416773,+p@chr6:78416766..78416773
+
Mm9::chr6:78416806..78416819,+p@chr6:78416806..78416819
+
Mm9::chr6:78416808..78416822,-p@chr6:78416808..78416822
-
Mm9::chr6:78416850..78416860,-p@chr6:78416850..78416860
-
Mm9::chr6:78416874..78416888,-p@chr6:78416874..78416888
-
Mm9::chr6:78417498..78417509,-p@chr6:78417498..78417509
-
Mm9::chr6:78417510..78417520,-p@chr6:78417510..78417520
-
Mm9::chr6:78417539..78417569,-p@chr6:78417539..78417569
-
Mm9::chr6:78417572..78417600,-p@chr6:78417572..78417600
-
Mm9::chr6:78417835..78417870,-p@chr6:78417835..78417870
-
Mm9::chr6:78417872..78417919,-p@chr6:78417872..78417919
-
Mm9::chr6:78418516..78418525,-p@chr6:78418516..78418525
-
Mm9::chr6:78418536..78418572,-p@chr6:78418536..78418572
-
Mm9::chr6:78418857..78418872,-p1@Reg3g
Mm9::chr7:108709377..108709380,-p1@Art2a-ps
Mm9::chr7:138141963..138141967,-p@chr7:138141963..138141967
-
Mm9::chr9:5299402..5299415,+p@chr9:5299402..5299415
+
Mm9::chr9:65270665..65270680,-p2@Ostb
Mm9::chr9:65270702..65270717,-p1@Ostb


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006953acute-phase response0.0275006151367407
GO:0035300inositol trisphosphate 5/6-kinase activity0.0278036487152797
GO:0051765inositol tetrakisphosphate kinase activity0.0278036487152797
GO:0047325inositol tetrakisphosphate 1-kinase activity0.0278036487152797
GO:0016176superoxide-generating NADPH oxidase activator activity0.0280353446395364
GO:0043647inositol phosphate metabolic process0.0280353446395364
GO:0032957inositol trisphosphate metabolic process0.0280353446395364
GO:0002526acute inflammatory response0.0280353446395364
GO:0006950response to stress0.0307422181886886



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}